For decades, researchers have worked to untangle the biological causes of neurodegenerative conditions such as Alzheimer’s disease. A primary focus has been the accumulation of misfolded proteins that ...

In the quest to cure Alzheimer's, the protein known as beta-amyloid has long taken center stage, driving development of a ...

A higher cumulative exposure to lead was linked to an increased risk of incident Alzheimer’s disease (AD) and all-cause dementia, according to a February study published in Alzheimer’s & Dementia.

This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS ...

Origami is collaborating with Ipsen to develop molecules designed to remove or correct abnormal proteins in neurodegenerative diseases.

SB 1047 is preceded by recent successful efforts in New York to drive FTD reporting infrastructure through legislation; last year, a bill championed by Sen. Michelle Hinchey (D--Kingston) and ...

Alzheimer's remains a shadow over millions of families, joined by other neurodegenerative diseases like Parkinson's.

Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...

Researchers are testing a fundamentally different strategy against neurodegenerative disease: instead of clearing protein deposits after they form, new experimental therapies aim to stop toxic protein ...